Your browser doesn't support javascript.
loading
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.
Dizdarevic, S; Tulchinsky, M; McCready, V R; Mihailovic, J; Vinjamuri, S; Buscombe, J R; Lee, S T; Frangos, S; Sathekge, M; Siraj, Q; Choudhury, P; Bom, H; Franceschi, M; Ugrinska, A; Paez, D; Hussain, R; Mailman, J; Luster, M; Virgolini, I.
Affiliation
  • Dizdarevic S; Department of Imaging and Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton and Sussex Medical School, Royal Sussex County Hospital, Brighton, UK.
  • Tulchinsky M; Radiology Department, Nuclear Medicine Section, Penn State University, Milton S. Hershey Medical Center, USA.
  • McCready VR; Department of Imaging and Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton and Sussex Medical School, Royal Sussex County Hospital, Brighton, UK.
  • Mihailovic J; Department of Nuclear Medicine, Oncology Institute of Vojvodina, Sremska Kamenica, University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia.
  • Vinjamuri S; Department of Nuclear Medicine, Royal Liverpool University Hospital, Liverpool, UK.
  • Buscombe JR; Department of Nuclear Medicine, Cambridge University Hospitals, Cambridge, UK.
  • Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.
  • Frangos S; Olivia Newton-John Cancer Research Institute, Heidelberg, Australia School of Cancer Medicine, La Trobe University, Heidelberg, Australia.
  • Sathekge M; Department of Nuclear Medicine, Bank of Cyprus Oncology Center, Nicosia, Cyprus.
  • Siraj Q; Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Choudhury P; Department of Nuclear Medicine, Farwania Hospital, Kuwait.
  • Bom H; Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Franceschi M; Department of Nuclear Medicine, Asian Regional Cooperative Council for Nuclear Medicine (ARCCNM), Chonnam National University Medical School, Gwangju, South Korea.
  • Ugrinska A; Department of Oncology and Nuclear Medicine, Sestre Milosrdnice, UHC, Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia, Faculty of Medicine, University of Osijek, Osijek, Croatia.
  • Paez D; Institute of Pathophysiology and Nuclear Medicine, Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia.
  • Hussain R; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
  • Mailman J; Nuclear Medicine and Molecular Imaging, Apollo Hospitals Dhaka, Society of Nuclear Medicine, Bangladesh (SNMB).
  • Luster M; World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), Oakland, CA, USA.
  • Virgolini I; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
World J Nucl Med ; 18(2): 123-126, 2019.
Article in En | MEDLINE | ID: mdl-31040741
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: World J Nucl Med Year: 2019 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: World J Nucl Med Year: 2019 Document type: Article Affiliation country: United kingdom